Luigi Elio Adinolfi
Luigi Elio Adinolfi
Full Professor of Internal Medicine, Director, University of Campania Luigi Vanvitelli Naples
Email verificata su
Citata da
Citata da
Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity
LE Adinolfi, M Gambardella, A Andreana, M Tripodi, R Utili, G Ruggiero
Hepatology 33 (6), 1358-1364, 2001
Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data
G Leandro, A Mangia, J Hui, P Fabris, L Rubbia–Brandt, G Colloredo, ...
Gastroenterology 130 (6), 1636-1642, 2006
Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease
A Lonardo, LE Adinolfi, P Loria, N Carulli, G Ruggiero, CP Day
Gastroenterology 126 (2), 586-597, 2004
Hepatitis B virus burden in developing countries
R Zampino, A Boemio, C Sagnelli, L Alessio, LE Adinolfi, E Sagnelli, ...
World journal of gastroenterology 21 (42), 11941, 2015
Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease: A decalogue from the Italian Association for the Study of the Liver (AISF) Expert …
P Loria, LE Adinolfi, S Bellentani, E Bugianesi, A Grieco, S Fargion, ...
Digestive and Liver Disease 42 (4), 272-282, 2010
Hepatic fibrosis plays a central role in the pathogenesis of thrombocytopenia in patients with chronic viral hepatitis
LE Adinolfi, MG Giordano, A Andreana, MF Tripodi, R Utili, G Cesaro, ...
British journal of haematology 113 (3), 590-595, 2001
A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients
Cancer of the Liver Italian Program (CLIP) Investigators
Hepatology 28 (3), 751-755, 1998
Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations
R Zampino, A Marrone, L Restivo, B Guerrera, A Sellitto, L Rinaldi, ...
World journal of hepatology 5 (10), 528, 2013
Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosis
LE Adinolfi, L Restivo, R Zampino, B Guerrera, A Lonardo, L Ruggiero, ...
Atherosclerosis 221 (2), 496-502, 2012
Nonalcoholic fatty liver disease: Evolving paradigms
A Lonardo, F Nascimbeni, M Maurantonio, A Marrazzo, L Rinaldi, ...
World journal of gastroenterology 23 (36), 6571, 2017
Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview.
MA Adinolfi LE, Nevola R, Lus G, Restivo L, Guerrera B, Romano C, Zampino R ...
World J Gastroenterol 21 (8), 2269-80, 2015
Chronic hepatitis C virus infection and atherosclerosis: clinical impact and mechanisms
LE Adinolfi, R Zampino, L Restivo, A Lonardo, B Guerrera, A Marrone, ...
World journal of gastroenterology: WJG 20 (13), 3410, 2014
Hepatitis C and steatosis: a reappraisal
A Lonardo, P Loria, LE Adinolfi, N Carulli, G Ruggiero
Journal of viral hepatitis 13 (2), 73-80, 2006
Serum HCV RNA levels correlate with histological liver damage and concur with steatosis in progression of chronic hepatitis C
LE Adinolfi, R Utili, A Andreana, MF Tripodi, M Marracino, M Gambardella, ...
Digestive diseases and sciences 46, 1677-1683, 2001
Prospective validation of the CLIP score: A new prognostic system for patients with cirrhosis and hepatocellular carcinoma
Pererrone F, Daniele B, Gaeta G, Pignata S, Gallo C, Izzo F, Cuomo O ...
Hepatology 31 (4), 840-45, 2000
The importance of telemedicine during COVID-19 pandemic: a focus on diabetic retinopathy
R Galiero, PC Pafundi, R Nevola, L Rinaldi, C Acierno, A Caturano, ...
Journal of diabetes research 2020, 2020
Hepatic steatosis and insulin resistance: does etiology make a difference?
A Lonardo, S Lombardini, F Scaglioni, L Carulli, M Ricchi, D Ganazzi, ...
Journal of hepatology 44 (1), 190-196, 2006
Hyperhomocysteinemia and the MTHFR C677T polymorphism promote steatosis and fibrosis in chronic hepatitis C patients
LE Adinolfi, D Ingrosso, G Cesaro, A Cimmino, M D'Antò, R Capasso, ...
Hepatology 41 (5), 995-1003, 2005
Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor‐α in chronic hepatitis C patients
E DURANTE‐MANGONI, R Zampino, A Marrone, MF TRIPODI, L Rinaldi, ...
Alimentary pharmacology & therapeutics 24 (9), 1349-1357, 2006
Risk factors for “major” embolic events in hospitalized patients with infective endocarditis
ED Mangoni, LE Adinolfi, MF Tripodi, A Andreana, M Gambardella, ...
American heart journal 146 (2), 311-316, 2003
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20